pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,792 catalysts · 3,189 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-06×clear all
type
  • 8k filing3,189
  • grant1,702
  • device adverse event1,000
  • approval795
  • device 510k621
  • earnings584
device pma
467
  • device recall191
  • phase 2 completion172
  • recall162
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 16, 2026

    50
    ›Feb 19, 2026device 510k175d agoMedtronic, Inc. — Retrograde Coronary Sinus Perfusion Cannulae (510k cleared)Medtronic plc

    Product code: DWF. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 19, 2026device 510k175d agoCenterPoint Systems, LLC — AuST CSP Introducer (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Feb 19, 2026device pma175d agoABBOTT MEDICAL — Aveir™ VR Leadless Pacemaker, Aveir™ Leadless Pacemaker (Right Ventricular) (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: PNJ. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoAlcon Laboratories, LLC — Clareon TruPlus Aspheric Hydrophobic Acrylic Intraocular Lens (IOL); Clareon TruPlus Toric Aspheric Hydrophobic Acrylic (PMA supplement)Alcon Laboratories Inc

    Supplement type: Real-Time Process. Product code: HQL. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoABBOTT MEDICAL — Quartet; QuickFlex Micro (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoBolton Medical, Inc. — TREO® Abdominal Stent-Graft System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoVeryan Medical, Ltd. — BioMimics 3D® Vascular Stent System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoABBOTT MEDICAL — Durata, Optisure (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoMedtronic Neuromodulation — Master Restore, Itrel, Synerg, Intellis, Vanta and Inceptiv Spinal Cord Stimulation Systems and Pisces, Specify, and Vec (PMA supplement)

    Supplement type: Real-Time Process. Product code: LGW. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoABBOTT MEDICAL — Tendril STS; OptiSense; UltiPace (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoBiomet Microfixation, Inc. — Total Temporomandibular Joint Replacement System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LZD. Advisory committee: DE. Decision: OK30

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoBolton Medical, Inc. — RelayPro Thoracic Stent-Graft System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MIH. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoABBOTT MEDICAL — IsoFlex (PMA supplement)

    Supplement type: 135 Review Track For 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device pma175d agoEdwards Lifesciences, LLC — SAPIEN M3 Transcatheter Mitral Valve Replacement System (PMA supplement)Edwards Lifesciences Corp

    Supplement type: Normal 180 Day Track No User Fee. Product code: NPU. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Feb 19, 2026device recall175d agoAMO Puerto Rico Manufacturing, Inc. device recall (Cls II)

    Brand Name: TECNIS Eyhance IOL with TECNIS Simplicity" Delivery System Product Name: TECNIS Eyhance IOL with TECNIS Simplicity" Delivery System Model/Catalog Number: DIB00 Software Version: N/A Product Description: The TECNIS SIMPLICITY" Delivery System is designed to provide a sterile,controlled and touch-free method of delivering the lens into the eye. The lens is preloaded and pre-assembled in the delivery system. The TECNIS SIMPLICITY" Delivery System Model DIB00 contains the TECNISEyhance" IOL, which is a one-piece, foldable, posterior chamber lens with an overall diameter of 13.0 mm and an optic diameter of 6.0 mm. The TECNIS SIMPLICITY" Delivery System is designed to provide a sterile,controlled and touch-free method of delivering the lens into the eye. Component: No — Reason: Due to identifying a limited quantity of intraocular lenses that may have a haptic that sticks to the optic which prevents the lens from unfolding as consistently as expected. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 19, 2026grant175d agoSTANFORD UNIVERSITY — Salmonella persistence in Mesenteric Lymph NodesStanford University

    AI grant. $771,210. PI: Denise M Monack

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoGEORGIA STATE UNIVERSITY — Nanobodies as effective therapeutic agents against H5N1 influenza virus

    AI grant. $434,938. PI: Lanying Du

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Role of nuclear paraspeckles in regulating HSV-1 infection in neurons

    AI grant. $250,682. PI: Leonardo D'Aiuto

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoTHOMAS JEFFERSON UNIVERSITY — Trained Immunity Induced by mRNA-LNP

    AI grant. $813,921. PI: Botond Z Igyarto

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoNATIONAL JEWISH HEALTH — Prenatal programming of immune cells for tissue repair and remodeling in asthmaTissue Repair Ltd

    AI grant. $776,394. PI: Magdalena Maria Gorska

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF ROCHESTER — LUNG CELLULAR SENESCENCE AND MOLECULAR CLOCK REV-ERBalpha BY ENVIRONMENTAL TO...University of Rochester

    ES grant. $906,000. PI: IRFAN RAHMAN

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Pseudomonas aeruginosa Carriage in the Gastrointestinal TractNorthwestern University

    AI grant. $431,784. PI: ALAN R HAUSER

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIV OF MARYLAND, COLLEGE PARK — Guiding innate signaling in skin with microneedle arrays to promote durable a...

    AI grant. $722,262. PI: Christopher M Jewell

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoGEORGIA INSTITUTE OF TECHNOLOGY — Mechanosensing through the B cell antigen receptor

    AI grant. $410,864. PI: Cheng Zhu

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoDUKE UNIVERSITY — Copper homeostasis in fungal pathogenesisDuke University

    AI grant. $482,071. PI: ANDREW ALSPAUGH

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Placental Serotonin: A Potential Mediator of Dieldrin-Related Neurotoxicity a...

    ES grant. $422,117. PI: Alison Bernstein

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoTULANE UNIVERSITY OF LOUISIANA — Alpha-satellite RNAs in Epstein-Barr virus lytic replication

    AI grant. $571,747. PI: Zhen Lin

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoBENAROYA RESEARCH INST AT VIRGINIA MASON — Dissecting how DYRK1A-gp130 axis drives immune dysregulation in Down syndrome...

    AI grant. $496,344. PI: Bernard Khor

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF WASHINGTON — Influenza Neuraminidase Structure and Dynamics:Resolving How Stalk Variation ...University of Washington

    AI grant. $414,305. PI: Kelly Keisen Lee

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoYALE UNIVERSITY — Studying ETS2-mediated monocyte activation in lupus

    AI grant. $462,052. PI: Insoo Kang

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Increasing kidney transplants with stratified kidney allocation: acceptabilit...New York University

    DK grant. $847,495. PI: Macey Leigh Levan

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoTUFTS UNIVERSITY BOSTON — Accelerating discovery of narrow-spectrum antibiotics for Lyme disease

    AI grant. $859,278. PI: Bree Beardsley Aldridge

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoOHIO STATE UNIVERSITY — Intrinsic STING signaling shapes phagocytosis-dependent innate immunity

    AI grant. $787,498. PI: Glen N. Barber

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoBOSTON CHILDREN'S HOSPITAL — Regulation of innate immunity by the pathogen Staphylococcus aureusBoston Children's Hospital

    AI grant. $800,557. PI: JONATHAN C KAGAN

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF COLORADO — Vesicle fusion regulation in metabolism

    DK grant. $551,250. PI: Jingshi Shen

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoDREXEL UNIVERSITY — Uncovering Mechanisms Contributing to Enhanced NeuroHIV with Cocaine Use

    DA grant. $48,996. PI: Tofunmi Oteju

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoHARVARD UNIVERSITY — Understanding programmed ribosomal frameshifting in coronaviruses

    AI grant. $414,029. PI: Victoria Manuel D'Souza

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — MitoPac female killing systems in mosquitoesUniversity of California San Diego

    AI grant. $439,375. PI: Omar Sultan Akbari

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Biophysical constraints on antibody affinity maturation to SARS-CoV-2University of California San Francisco

    AI grant. $815,762. PI: Angela Marie Phillips

    full page →nih reporter ↗
    ›Feb 19, 2026grant175d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Deciphering the Interplay of Depleting Anti-PD-1 Antibodies and Autoimmune En...University of Utah

    AI grant. $756,078. PI: Mingnan Chen

    full page →nih reporter ↗
    ›Feb 20, 2026approval174d agoFAVLYXA (FLUOROURACIL) — FDA approvalEfudex

    Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS

    full page →Efudex →fda approvals ↗
    ›Feb 20, 2026approval174d agoRIVAROXABAN — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 20, 2026approval174d agoBYSANTI (MILSAPERIDONE) — FDA approvalVanda Pharmaceuticals Inc.

    Sponsor: VANDA PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 20, 2026approval174d agoELUCIREM (GADOPICLENOL) — FDA approval

    Sponsor: GUERBET. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 20, 2026approval174d agoVABOMERE (MEROPENEM) — FDA approvalHQ Speciality Pharma

    Sponsor: REMPEX. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 20, 2026approval174d agoZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalloncastuximab tesirine

    Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION

    full page →loncastuximab tesirine →fda approvals ↗
    ›Feb 20, 2026approval174d agoHEPARIN SODIUM — FDA approvalPharmacia & Upjohn LLC

    Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 20, 2026approval174d agoHEPARIN SODIUM — FDA approvalPharmacia & Upjohn LLC

    Sponsor: EMERGE BIOSCIENCE. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 20, 2026device 510k174d agoSoterix Medical, Inc. — SPRY TMS Therapy System (0550) (510k cleared)

    Product code: OBP. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 20, 2026device 510k174d agoForeo, Inc. — FAQ™ (LED Panel); FAQ™ (Dual LED Panel) (510k cleared)

    Product code: OHS. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 17 of 176
    next →
    $MDT90.76+0.09%
    $VNDA5.3300+1.91%
    $EW91.33-2.47%
    $ADCT1.0500-5.41%